U.S.-based pharmaceutical giant Eli Lilly has officially launched its widely popular drug, Mounjaro, in India. Containing the active ingredient tirzepatide, the medication is designed for managing type 2 diabetes, blood sugar levels, and weight, offering a new hope for millions of Indians struggling with obesity and diabetes. Mounjaro, a once-weekly injectable prescription drug, has been […]

The post Mounjaro: A Game-Changer in Diabetes and Obesity Treatment, Launched in India appeared first on Pragativadi I Latest Odisha News in English I Breaking News .